BAY CITY CAPITAL LLC's Net Worth
$242 Million
Who is BAY CITY CAPITAL LLC?
BAY CITY CAPITAL LLC has an estimated net worth of $242 Million. This is based on reported shares across multiple companies, which include DIAMETRICS MEDICAL INC, EnteroMedics Inc, MADRIGAL PHARMACEUTICALS, INC., HYPERION THERAPEUTICS INC, Kezar Life Sciences, Inc., NEVRO CORP, Dermira, Inc., Xilio Therapeutics, Inc., PONIARD PHARMACEUTICALS, INC., Epizyme, Inc., SUNESIS PHARMACEUTICALS INC, IMARA Inc., INTERLEUKIN GENETICS INC, and VIA Pharmaceuticals, Inc..
SEC CIK
BAY CITY CAPITAL LLC's CIK is 0001288452
Past Insider Trading and Trends
2007 was BAY CITY CAPITAL LLC's most active year for acquiring shares with 62 total transactions. BAY CITY CAPITAL LLC's most active month to acquire stocks was the month of July. 2013 was BAY CITY CAPITAL LLC's most active year for disposing of shares, totalling 44 transactions. BAY CITY CAPITAL LLC's most active month to dispose stocks was the month of June. 2009 saw BAY CITY CAPITAL LLC paying a total of $15,541,362.52 for 109,405,214 shares, this is the most they've acquired in one year. In 2019 BAY CITY CAPITAL LLC cashed out on 1,200,000 shares for a total of $126,564,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMARA Inc. (ELVN) Snapshot price: $15.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 703.38K |
—
|
—
| 703.38K |
Mar 16
| |||
Form 4
|
∞
| 703.38K |
—
|
—
| 703.38K |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.67% | 840K |
$1.65 | $1,386,000.00 | 4.9M |
Sep 23
| |||
Form 4
| +104.70% | 3.33M |
$1.74 | $2,958,000.00 | 6.5M |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +59.31% | 1.65M |
$1.15 | $1,896,907.75 | 4.43M |
Feb 19
| |||
Form 4
| +1.82% | 49.6K |
$1.10 | $54,560.00 | 2.78M |
Oct 24
| |||
Form 4
| +0.92% | 25K |
$4.50 | $112,500.00 | 2.73M |
Apr 29
| |||
Form 4
| +1.88% | 50K |
$4.50 | $225,000.00 | 2.71M |
Apr 24
| |||
Form 4
| +0.80% | 21K |
$8.66 | $181,860.00 | 2.66M |
Feb 29
| |||
Form 4
| +602.80% | 2.26M |
—
|
—
| 2.64M |
Nov 20
| |||
Form 4
|
∞
| 375K |
$8.00 | $3,000,000.00 | 375K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Snapshot price: $187.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.28% | -824.17K |
—
|
—
| 1.51M |
Dec 3
| |||
Form 4
| -1.85% | -43.54K |
—
|
—
| 2.31M |
Dec 1
| |||
Form 4
| -39.63% | -1.55M |
—
|
—
| 2.35M |
Sep 4
| |||
Form 4
| -41.17% | -30.00K |
$109.74 | -$3,292,195.83 | 42.88K |
Aug 17 - Aug 19
| |||
Form 4
| -9.60% | -412.24K |
—
|
—
| 3.88M |
May 27
| |||
Form 4
| -22.31% | -1.20M |
$105.47 | -$126,564,000.00 | 4.18M |
Dec 13
| |||
Form 4
| -4.95% | -280.00K |
$287.46 | -$80,488,800.00 | 5.38M |
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HYPERION THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.45% | -200.00K |
$26.00 | -$5,200,000.00 | 1.92M |
Oct 18
| |||
Form 4
| -1.49% | -95.90K |
$26.23 | -$2,497,066.00 | 6.36M |
Jul 17 - Jul 19
| |||
Form 4/A
| -1.17% | -52.93K |
$22.42 | -$1,183,055.98 | 4.47M |
Jul 9 - Jul 10
| |||
Form 4/A
| -0.26% | -11.70K |
$22.50 | -$263,250.00 | 4.54M |
Jul 5 - Jul 8
| |||
Form 4
| -1.17% | -52.93K |
$22.42 | -$1,183,055.98 | 4.48M |
Jul 9 - Jul 10
| |||
Form 4
| -0.33% | -22.30K |
$22.50 | -$501,815.17 | 6.82M |
Jul 3 - Jul 8
| |||
Form 4
| -0.56% | -25.86K |
$22.52 | -$582,392.35 | 4.59M |
Jun 27 - Jun 28
| |||
Form 4
| +0.24% | 11.28K |
$5.70 | $52,911.82 | 4.62M |
May 23
| |||
Form 4
| -0.38% | -17.37K |
$21.04 | -$365,646.00 | 4.61M |
May 28 - May 30
| |||
Form 4
| -2.75% | -131.46K |
$22.47 | -$2,981,813.95 | 4.64M |
May 17 - May 20
| |||
Form 4
| +30.13% | 2.45M |
$10.00 | $11,411,480.00 | 10.59M |
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.949
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 622.23K |
$15.00 |
—
| 622.23K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||